Metastatic and histologic presentations in unknown primary cancer
- PMID: 841350
Metastatic and histologic presentations in unknown primary cancer
Abstract
The patient with metastatic adeno- or undifferentiated carcinoma who presents with a cryptic primary is subjected to an extensive diagnostic search. These efforts apparently stem from the following assumptions: 1). The ultimately proven primary sites in such patients will occur with the same frequency as the most commonly occurring carcinomas (i.e., lung, breast, colon, prostate, etc.); and 2). Metastatic patterns and histologies seen at diagnosis are the same as for patients presenting with these more common tumors. Our data contradict these assumptions. For example, the most commonly occurring unknown primary was pancreas. Rarely occurring primaries included breast and prostate. Lung cancer was observed frequently, but the presentation was atypical because of the large proportion of female patients. In addition, the metastatic patterns at diagnosis were unusual for many of the ultimately proven primary sites. In an attempt to deal with these contradictions, a method to search for new relationships between primary site and metastatic-histologic presentations was employed. This method succeeded in placing the location of the primary cancer to above or below the diaphragm in 80% of the patients studied retrospectively. Tested prospectively in a small group of patients, the method appears to be clincally useful. Finally, in this study we have made the diagnosis, antemortem, of the primary cancer site (PCS) in only 30 of 264 patients. The failure to find the primary site, dispite extensive radiologic work-up, was disappointing to the authors, and emphasizes the difficulty of finding PCS antemortem. In our study pancreas and lung appear to be most common cryptic primary sites.
Similar articles
-
[Asymptomatic thoracic and abdominal tumors with lymph nodes metastasis as a reason for consultation].An Otorrinolaringol Ibero Am. 1996;23(2):161-8. An Otorrinolaringol Ibero Am. 1996. PMID: 8669548 Spanish.
-
Palpable lesions as a diagnostic tool in patients with thoracic pathology.Diagn Cytopathol. 2013 Jan;41(1):28-34. doi: 10.1002/dc.21755. Epub 2011 Jun 16. Diagn Cytopathol. 2013. PMID: 21681977
-
Carcinoma of unknown primary site: a clinical enigma.Arch Intern Med. 1982 Feb;142(2):357-9. Arch Intern Med. 1982. PMID: 7059260
-
[Cutaneous metastases from adenocarcinoma of unknown primary site].Actas Dermosifiliogr. 2006 Dec;97(10):662-5. doi: 10.1016/s0001-7310(06)73490-1. Actas Dermosifiliogr. 2006. PMID: 17173831 Review. Spanish.
-
Carcinoma with unknown primary tumor (CUP syndrome).South Med J. 1981 Dec;74(12):1497-502. doi: 10.1097/00007611-198112000-00021. South Med J. 1981. PMID: 6171892 Review.
Cited by
-
Tumour marker immunoreactivity in adenocarcinoma.J Clin Pathol. 1988 Oct;41(10):1064-7. doi: 10.1136/jcp.41.10.1064. J Clin Pathol. 1988. PMID: 3192728 Free PMC article.
-
Differentiation of gastric adenocarcinoma and pancreatic adenocarcinoma using immunohistochemistry biomarkers: a systematic review and meta-analysis study.Gastroenterol Hepatol Bed Bench. 2024;17(4):324-337. doi: 10.22037/ghfbb.v17i4.3057. Gastroenterol Hepatol Bed Bench. 2024. PMID: 40406435 Free PMC article. Review.
-
Unknown primary tumours.Postgrad Med J. 2000 Nov;76(901):690-3. doi: 10.1136/pmj.76.901.690. Postgrad Med J. 2000. PMID: 11060142 Free PMC article. Review.
-
Carcinoma of Unknown Primary - an Orphan Disease?Breast Care (Basel). 2008;3(3):164-170. doi: 10.1159/000136001. Epub 2008 Jun 19. Breast Care (Basel). 2008. PMID: 20824034 Free PMC article.
-
Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.Virchows Arch. 2014 Apr;464(4):393-402. doi: 10.1007/s00428-014-1545-2. Epub 2014 Feb 1. Virchows Arch. 2014. PMID: 24487792 Review.